Finasteride-associated male infertility
Autor(a) principal: | |
---|---|
Data de Publicação: | 2004 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista do Hospital das Clínicas |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000400009 |
Resumo: | Finasteride is a potent and specific inhibitor of the 5alpha-reductase enzyme in men. Clinical studies have shown that finasteride 1mg/day is effective for promoting hair growth in men with male pattern hair loss. However, there is a concern about the use of finasteride, especially in young fertile patients, because of its action on testosterone metabolism. This paper describes 3 cases of young patients who had very poor seminal quality during finasteride treatment (1 mg/day), and their seminal quality greatly improved after cessation of finasteride treatment. Two of them presented with a left varicocele and the other was obese. We hypothesize that finasteride may not dramatically change the spermatogenesis process in healthy men, but in patients with conditions related to infertility, an amplification of the negative influence of finasteride could occur. Future studies should be done to clarify the extent of the effect of finasteride in patients fertility problems. |
id |
USP-57_cf170b109ce2f349bb4c07f0858f843c |
---|---|
oai_identifier_str |
oai:scielo:S0041-87812004000400009 |
network_acronym_str |
USP-57 |
network_name_str |
Revista do Hospital das Clínicas |
repository_id_str |
|
spelling |
Finasteride-associated male infertilityFinasterideFertilitySpermatogenesisSpermSeminal parametersFinasteride is a potent and specific inhibitor of the 5alpha-reductase enzyme in men. Clinical studies have shown that finasteride 1mg/day is effective for promoting hair growth in men with male pattern hair loss. However, there is a concern about the use of finasteride, especially in young fertile patients, because of its action on testosterone metabolism. This paper describes 3 cases of young patients who had very poor seminal quality during finasteride treatment (1 mg/day), and their seminal quality greatly improved after cessation of finasteride treatment. Two of them presented with a left varicocele and the other was obese. We hypothesize that finasteride may not dramatically change the spermatogenesis process in healthy men, but in patients with conditions related to infertility, an amplification of the negative influence of finasteride could occur. Future studies should be done to clarify the extent of the effect of finasteride in patients fertility problems.Faculdade de Medicina / Universidade de São Paulo - FM/USP2004-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000400009Revista do Hospital das Clínicas v.59 n.4 2004reponame:Revista do Hospital das Clínicasinstname:Universidade de São Paulo (USP)instacron:USP10.1590/S0041-87812004000400009info:eu-repo/semantics/openAccessGlina,SidneyNeves,Paulo AugustoSaade,RicardoNetto Jr.,Nelson RodriguesSoares,Jonathas BorgesGaluppo,Andrea Giannottieng2004-09-09T00:00:00Zoai:scielo:S0041-87812004000400009Revistahttp://www.scielo.br/rhcPUBhttps://old.scielo.br/oai/scielo-oai.php||revista.hc@hcnet.usp.br1678-99030041-8781opendoar:2004-09-09T00:00Revista do Hospital das Clínicas - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Finasteride-associated male infertility |
title |
Finasteride-associated male infertility |
spellingShingle |
Finasteride-associated male infertility Glina,Sidney Finasteride Fertility Spermatogenesis Sperm Seminal parameters |
title_short |
Finasteride-associated male infertility |
title_full |
Finasteride-associated male infertility |
title_fullStr |
Finasteride-associated male infertility |
title_full_unstemmed |
Finasteride-associated male infertility |
title_sort |
Finasteride-associated male infertility |
author |
Glina,Sidney |
author_facet |
Glina,Sidney Neves,Paulo Augusto Saade,Ricardo Netto Jr.,Nelson Rodrigues Soares,Jonathas Borges Galuppo,Andrea Giannotti |
author_role |
author |
author2 |
Neves,Paulo Augusto Saade,Ricardo Netto Jr.,Nelson Rodrigues Soares,Jonathas Borges Galuppo,Andrea Giannotti |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Glina,Sidney Neves,Paulo Augusto Saade,Ricardo Netto Jr.,Nelson Rodrigues Soares,Jonathas Borges Galuppo,Andrea Giannotti |
dc.subject.por.fl_str_mv |
Finasteride Fertility Spermatogenesis Sperm Seminal parameters |
topic |
Finasteride Fertility Spermatogenesis Sperm Seminal parameters |
description |
Finasteride is a potent and specific inhibitor of the 5alpha-reductase enzyme in men. Clinical studies have shown that finasteride 1mg/day is effective for promoting hair growth in men with male pattern hair loss. However, there is a concern about the use of finasteride, especially in young fertile patients, because of its action on testosterone metabolism. This paper describes 3 cases of young patients who had very poor seminal quality during finasteride treatment (1 mg/day), and their seminal quality greatly improved after cessation of finasteride treatment. Two of them presented with a left varicocele and the other was obese. We hypothesize that finasteride may not dramatically change the spermatogenesis process in healthy men, but in patients with conditions related to infertility, an amplification of the negative influence of finasteride could occur. Future studies should be done to clarify the extent of the effect of finasteride in patients fertility problems. |
publishDate |
2004 |
dc.date.none.fl_str_mv |
2004-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000400009 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000400009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0041-87812004000400009 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina / Universidade de São Paulo - FM/USP |
publisher.none.fl_str_mv |
Faculdade de Medicina / Universidade de São Paulo - FM/USP |
dc.source.none.fl_str_mv |
Revista do Hospital das Clínicas v.59 n.4 2004 reponame:Revista do Hospital das Clínicas instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista do Hospital das Clínicas |
collection |
Revista do Hospital das Clínicas |
repository.name.fl_str_mv |
Revista do Hospital das Clínicas - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||revista.hc@hcnet.usp.br |
_version_ |
1754820894816993280 |